TURIN, Italy--(BUSINESS WIRE)--June 29, 2005--Bioindustry Park Canavese Spa and Eporgen Venture Spa announced today the start-up of six new biotechnology companies, as result of the joint project Discovery. Euro 3m of private capital, Euro 2.7m of public investment, 18 researchers from academia and state research centres who have become entrepreneurs: these are the main figures of the enterprise announced today. The companies have established their headquarters in the Bioincubator, created by the Bioindustry Park (www.bioindustrypark.it) with the support of the Piedmont Region Authority. The companies - BioNucleon, Biopaint, Eicosamed, Narvalus, Spider Biotech and Target Heart - operate in the molecular biology, technologies applicable to industrial processes, chemical, and environmental sectors.
